Clinical Trials Logo

Filter by:
NCT ID: NCT05229562 Completed - Healthy Volunteer Clinical Trials

A Study to See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy Adult Japanese, Chinese, and Caucasian Participants

Start date: February 17, 2022
Phase: Phase 1
Study type: Interventional

The study will be looking at an investigational drug, BIIB122, in healthy adult Japanese, Chinese, and Caucasian participants. The main goal of the study is to compare the drug level achieved in the body, between the different ethnic groups, after single and multiple doses of BIIB122. Researchers also want to see if single and multiple doses of BIIB122 are safe and if healthy participants can tolerate given doses of BIIB122.

NCT ID: NCT05229445 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Continuous Glucose Monitor Based Insulin Bolus Calculator

CGM-IBC
Start date: July 5, 2022
Phase: N/A
Study type: Interventional

This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor

NCT ID: NCT05229406 Completed - Depression Clinical Trials

Healthy Minds Program App Dosage

Start date: February 21, 2022
Phase: Phase 1
Study type: Interventional

The study will evaluate the effectiveness of the Healthy Minds Program (HMP) meditation app on participants experiencing depression and/or anxiety. Participants will be assigned to use the HMP app 5- or 15-minutes per day for 4 weeks.

NCT ID: NCT05229146 Completed - Behavioral Health Clinical Trials

Improving Future Thinking Among Mothers to Reduce Harsh Parenting and Improve Child Outcomes

Start date: June 2, 2022
Phase: N/A
Study type: Interventional

Parents of children from impoverished communities are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including suicidal ideation and attempts. One mechanism linking low resource environments and maladaptive parenting strategies is maternal delay discounting, or the tendency to value smaller, immediate rewards (such as stopping children's misbehavior via physical means) relative to larger, but delayed rewards (like improving the parent-child relationship). This study will examine the efficacy of implementing a low-cost, brief intervention targeting the reduction of maternal delay discounting to inform broader public health efforts aimed at improving adolescent mental health outcomes in traditionally underserved communities.

NCT ID: NCT05229120 Completed - Behavioral Health Clinical Trials

Improving Delay Discounting to Decrease Harsh Parenting Among Parents Receiving Substance Use Treatment

Start date: April 7, 2022
Phase: N/A
Study type: Interventional

Parents with substance use disorders are disproportionately more likely to engage in harsh physical discipline, which can lead to serious clinical outcomes, including child maltreatment and the intergenerational transmission of addictive disorders. One mechanism linking substance use and maladaptive parenting strategies is parental delay discounting, or the tendency to value smaller, immediate rewards (such as stopping children's misbehavior via physical punishment) relative to larger, but delayed rewards (like shaping adaptive child behaviors over time). This study will examine the efficacy of implementing a low-cost, brief intervention targeting the reduction of parental delay discounting to inform broader public health efforts aimed at reducing child maltreatment and interrupting intergenerational cycles of substance abuse in traditionally underserved communities.

NCT ID: NCT05229016 Completed - Clinical trials for Patient Participation

Priming and Patient Reported Outcome Measures

Start date: November 9, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to assess which health-related questionnaire is the most accurate and reliable. The hypothesis is that some health-related questionnaires are more reliable than others.

NCT ID: NCT05228899 Completed - COVID-19 Clinical Trials

Zofin to Treat COVID-19 Long Haulers

Start date: April 14, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and potential efficacy of Zofin administered intravenously in subjects experiencing prolonged symptoms (> 6 weeks and < 24 months) of COVID-19.

NCT ID: NCT05228457 Completed - Clinical trials for Treatment Resistant Depression

Intensive TMS for Bipolar Depression

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The research study is being conducted to test whether using high dose spaced theta-burst rTMS (a form of transcranial magnetic stimulation) produces a significant reduction in depressive symptoms compared with sham. This project will recruit patients aged 18-70 with symptoms of bipolar depression who have failed (or not shown signs of improvement) after at least two prior treatments.

NCT ID: NCT05228171 Completed - Healthy Clinical Trials

Mobile Food Record on Recall Effects

Start date: March 14, 2022
Phase:
Study type: Observational

Human dietary habits remain challenging to measure. Even the "gold-standard" interviewer-administered 24 hour dietary recall has established underreporting issues especially in high-risk populations, such as patients with obesity. Performance of precision nutrition research requires state of the art tools to capture individual dietary patterns. Given the widespread availability of smart phones, mobile-phone based food records present a prime opportunity to capture "in the field" dietary intake. Mobile food records, however, are not yet widely used in nutrition research. Several reasons exist. First, the mobile food record needs to be validated relative to the "gold standard" of dietary intake, the 24-hour dietary recall. Second, many available mobile food records are commercially based, with caveats about data availability and meeting research-quality data security practices (HIPAA compliance). In response, this study includes using a freely available, research-focused, HIPAA compliant, mobile food record (mCC: my Circadian Clock app) actively used in research studies (including our own ongoing work) to test the hypothesis that a mobile food record can expand capture of dietary intake. The proposed aims include the following: Using a randomized, cross-over design, evaluation of augmenting interviewer-administered 24-hour dietary recalls by a mobile food record (Augmented Recall) results in less energy intake underreporting than a standard (un-augmented) interviewer administered 24-hour dietary recall (Standard Recall).

NCT ID: NCT05227820 Completed - Alzheimer Disease Clinical Trials

Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia

Start date: January 19, 2022
Phase: Phase 2
Study type: Interventional

This study seeks to measure changes in cognition through verbal and visual test procedures and changes in biomarkers of Alzheimer's disease and inflammatory and metabolic parameters that can be measure in the central nervous system (CNS) with advanced neuroimaging techniques in patients treated with NE3107 (17a-ethynyl-androst-5-3b,7b,17b-triol).